These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6543385)

  • 21. Phenylclindine-induced alteration in rat muscarinic cholinergic receptor regulation.
    Ward D; Trevor A
    Eur J Pharmacol; 1981 Sep; 74(2-3):189-93. PubMed ID: 7327201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated noise exposure affects muscarinic cholinergic receptors in the rat brain.
    Lai H; Carino MA; Wen YF
    Brain Res; 1989 May; 488(1-2):361-4. PubMed ID: 2743133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic muscarinic receptors in rat cochlea.
    van Megen YJ; Klaassen AB; Rodrigues de Miranda JF; Kuijpers W
    Brain Res; 1988 Nov; 474(1):185-8. PubMed ID: 3214711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
    Mittal CK
    Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
    [No Abstract]   [Full Text] [Related]  

  • 26. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum.
    Das S; Bhargava HN
    Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic acetylcholine receptors in bulk-isolated astrocytes of the hippocampus in the rat.
    Ułas J
    Acta Neurobiol Exp (Wars); 1988; 48(1):41-8. PubMed ID: 3407450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic cholinergic receptors in developing rat lung.
    Whitsett JA; Hollinger B
    Pediatr Res; 1984 Nov; 18(11):1136-40. PubMed ID: 6514439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T; Tsukahara T; Fujiwara M
    Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
    Watson M; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of fentanyl and pethidine to muscarinic receptors in rat brain.
    Hustveit O
    Jpn J Pharmacol; 1994 Jan; 64(1):57-9. PubMed ID: 8164394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
    Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance, physical dependence and changes in muscarinic receptor binding sites after chronic ethanol treatment in the rat.
    Nordberg A; Wahlström G
    Life Sci; 1982 Jul; 31(3):277-87. PubMed ID: 6889663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states.
    Geary WA; Wooten GF
    Brain Res; 1985 Dec; 360(1-2):214-23. PubMed ID: 4075170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL; Dawson TM; Wamsley JK
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.